« Back
Home /
Elacestrant

Elacestrant

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Breast Cancer
Type	Inhibitors
Specific against	other
Amount	50 mg
Quantity options	100 mg 10 mg 1 mg 50 mg 5 mg
Item no.	HY-19822-50mg
Targets	Estrogen Receptor/ERR
CASRN	722533-56-4
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Elacestrant (RAD1901) is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also can inhibit growth of ER+ breast cancer cell lines in vitro and in vivo[1][2].
StorageTemperature	4°C (Powder, sealed storage, away from moisture and light)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	458.63
Clinical_Information	Launched
Manufacturers Research_Area	Cancer
Solubility	DMSO : 160 mg/mL (ultrasonic)
Manufacturers Target	Estrogen Receptor/ERR
Manufacturers Pathway	Vitamin D Related/Nuclear Receptor
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Request delivery time